These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25597749)

  • 1. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
    Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
    Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
    J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.
    Liu X; Zhang Y; Zhu Z; Ha M; Wang Y
    Med Oncol; 2014 Aug; 31(8):85. PubMed ID: 24996799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
    Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
    Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
    Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
    Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum YKL-40 and colorectal cancer.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Br J Cancer; 1999 Mar; 79(9-10):1494-9. PubMed ID: 10188896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
    Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
    Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum YKL-40 level with tumor burden and metastatic stage of prostate cancer.
    Özdemir E; Çiçek T; Kaya MO
    Urol J; 2012; 9(3):568-73. PubMed ID: 22903479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40 levels and atrial fibrillation in the general population.
    Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
    Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
    Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
    BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients.
    Ye HM; Lu YZ; Liang XM; Lin YZ; Li Y; Zhang ZY; Tzeng CM
    Clin Lab; 2014; 60(3):397-405. PubMed ID: 24697115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
    Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL
    Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YKL-40 protein correlates with the phenotype of asthma.
    Specjalski K; Chełmińska M; Jassem E
    Lung; 2015 Apr; 193(2):189-94. PubMed ID: 25663327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†).
    Hvolris MH; Piper TB; Hammer E; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Christensen IJ; Brünner N; Johansen JS; Davis GJ; Dowell BL; Nielsen HJ
    Scand J Gastroenterol; 2016 Jul; 51(7):860-5. PubMed ID: 26918701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the inflammatory protein YKL-40 in precancers of the breast.
    Qin W; Zhu W; Schlatter L; Miick R; Loy TS; Atasoy U; Hewett JE; Sauter ER
    Int J Cancer; 2007 Oct; 121(7):1536-42. PubMed ID: 17565739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.